{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:51:32Z","timestamp":1791967892586,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023915","name":"Faculty of Dentistry, Chulalongkorn University","doi-asserted-by":"publisher","award":["3200502#30\/2023"],"award-info":[{"award-number":["3200502#30\/2023"]}],"id":[{"id":"10.13039\/501100023915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Odontology"],"DOI":"10.1007\/s10266-026-01580-4","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:17:20Z","timestamp":1791940640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sirtuin 4 is downregulated in oral carcinogenesis"],"prefix":"10.1007","author":[{"given":"Tanatat","family":"Apiwessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paranin","family":"Chaicharncheep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Yodsanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theerapat","family":"Chanamuangkon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5940-7935","authenticated-orcid":false,"given":"Ekarat","family":"Phattarataratip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"issue":"4","key":"1580_CR1","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/biomedicines11041112","volume":"11","author":"M Imbesi Bellantoni","year":"2023","unstructured":"Imbesi Bellantoni M, Picciolo G, Pirrotta I, Irrera N, Vaccaro M, Vaccaro F, Squadrito F, Pallio G. Oral Cavity Squamous Cell Carcinoma: An Update of the Pharmacological Treatment. Biomedicines. 2023;11(4):1112.","journal-title":"Biomedicines"},{"issue":"12","key":"1580_CR2","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/hed.21131","volume":"31","author":"HM Mehanna","year":"2009","unstructured":"Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 2009;31(12):1600\u20139.","journal-title":"Head Neck"},{"issue":"100664","key":"1580_CR3","first-page":"100664","volume":"34","author":"R Ellonen","year":"2023","unstructured":"Ellonen R, Suominen A, Kelppe J, Willberg J, Rautava J, Laine H. Histopathological findings of oral epithelial dysplasias and their relation to malignant transformation. Cancer Treat Res Commun. 2023;34(100664):100664.","journal-title":"Cancer Treat Res Commun"},{"issue":"1","key":"1580_CR4","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.1038\/s41598-022-12441-9","volume":"12","author":"TT Nevanp\u00e4\u00e4","year":"2022","unstructured":"Nevanp\u00e4\u00e4 TT, Ter\u00e4v\u00e4 AE, Laine HK, Rautava J. Malignant transformation of oral epithelial dysplasia in Southwest Finland. Sci Rep. 2022;12(1):8261.","journal-title":"Sci Rep"},{"issue":"8","key":"1580_CR5","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/odi.13993","volume":"27","author":"E Odell","year":"2021","unstructured":"Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021;27(8):1947\u201376.","journal-title":"Oral Dis"},{"issue":"1","key":"1580_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00784-019-02871-7","volume":"24","author":"S Pariyawathee","year":"2020","unstructured":"Pariyawathee S, Phattarataratip E, Thongprasom K. CD146 expression in oral lichen planus and oral cancer. Clin Oral Investig. 2020;24(1):325\u201332.","journal-title":"Clin Oral Investig"},{"issue":"4","key":"1580_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.identj.2024.01.011","volume":"74","author":"W Tachaveeraphong","year":"2024","unstructured":"Tachaveeraphong W, Phattarataratip E. The Significance of Modified Histone H3 in Epithelial Dysplasia and Oral Cancer. Int Dent J. 2024;74(4):769\u201376.","journal-title":"Int Dent J"},{"issue":"4","key":"1580_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/ncb3124","volume":"17","author":"LK Boroughs","year":"2015","unstructured":"Boroughs LK, DeBerardinis RJ. Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol. 2015;17(4):351\u20139.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1580_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fendo.2018.00783","volume":"9","author":"Z Min","year":"2018","unstructured":"Min Z, Gao J, Yu Y. The roles of mitochondrial SIRT4 in cellular metabolism. Front Endocrinol (Lausanne). 2018;9:783.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1580_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.gde.2014.05.005","volume":"26","author":"JE Choi","year":"2014","unstructured":"Choi JE, Mostoslavsky R. Sirtuins, metabolism, and DNA repair. Curr Opin Genet Dev. 2014;26:24\u201332.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"1580_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-016-0461-5","volume":"35","author":"Z Mei","year":"2016","unstructured":"Mei Z, Zhang X, Yi J, Huang J, He J, Tao Y. Sirtuins in metabolism, DNA repair and cancer. J Exp Clin Cancer Res. 2016;35(1):182.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-15-2733","volume":"76","author":"J George","year":"2016","unstructured":"George J, Ahmad N. Mitochondrial sirtuins in cancer: Emerging roles and therapeutic potential. Cancer Res. 2016;76(9):2500\u20136.","journal-title":"Cancer Res"},{"issue":"4","key":"1580_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2013.04.003","volume":"23","author":"PJ Fernandez-Marcos","year":"2013","unstructured":"Fernandez-Marcos PJ, Serrano M. Sirt4: the glutamine gatekeeper. Cancer Cell. 2013;23(4):427\u20138.","journal-title":"Cancer Cell"},{"key":"1580_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3389\/fonc.2020.00474","volume":"10","author":"D Tomaselli","year":"2020","unstructured":"Tomaselli D, Steegborn C, Mai A, Rotili D. Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer. Front Oncol. 2020;10:474.","journal-title":"Front Oncol"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.biopha.2015.04.013","volume":"72","author":"G Huang","year":"2015","unstructured":"Huang G, Cui F, Yu F, Lu H, Zhang M, Tang H, Peng Z. Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma. Biomed Pharmacother. 2015;72:135\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1580_CR17","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3892\/or.2016.4685","volume":"35","author":"G Huang","year":"2016","unstructured":"Huang G, Cheng J, Yu F, Liu X, Yuan C, Liu C, Chen X, Peng Z. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Oncol Rep. 2016;35(5):2801\u201310.","journal-title":"Oncol Rep"},{"issue":"3","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/bjc.2015.226","volume":"113","author":"M Miyo","year":"2015","unstructured":"Miyo M, Yamamoto H, Konno M, Colvin H, Nishida N, Koseki J, Kawamoto K, Ogawa H, Hamabe A, Uemura M, et al. Tumour-suppressive function of SIRT4 in human colorectal cancer. Br J Cancer. 2015;113(3):492\u20139.","journal-title":"Br J Cancer"},{"issue":"6","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.7150\/thno.42874","volume":"10","author":"T Li","year":"2020","unstructured":"Li T, Li Y, Liu T, Hu B, Li J, Liu C, Liu T, Li F. Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex. Theranostics. 2020;10(6):2571\u201386.","journal-title":"Theranostics"},{"key":"1580_CR20","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.2147\/OTT.S189536","volume":"12","author":"Z Chen","year":"2019","unstructured":"Chen Z, Lin J, Feng S, Chen X, Huang H, Wang C, Yu Y, He Y, Han S, Zheng L, et al. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism. Onco Targets Ther. 2019;12:2397\u2013408.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1580_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.18632\/oncotarget.6691","volume":"7","author":"C Bartosch","year":"2016","unstructured":"Bartosch C, Monteiro-Reis S, Almeida-Rios D, Vieira R, Castro A, Moutinho M, Rodrigues M, Graca I, Lopes JM, Jeronimo C. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium. Oncotarget. 2016;7(2):1144\u201354.","journal-title":"Oncotarget"},{"issue":"4","key":"1580_CR22","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3892\/ol.2016.5021","volume":"12","author":"Q Shi","year":"2016","unstructured":"Shi Q, Liu T, Zhang X, Geng J, He X, Nu M, Pang D. Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer. Oncol Lett. 2016;12(4):2606\u201312.","journal-title":"Oncol Lett"},{"issue":"19","key":"1580_CR23","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1038\/onc.2016.425","volume":"36","author":"L Fu","year":"2017","unstructured":"Fu L, Dong Q, He J, Wang X, Xing J, Wang E, Qiu X, Li Q. SIRT4 inhibits malignancy progression of NSCLCs, through mitochondrial dynamics mediated by the ERK-Drp1 pathway. Oncogene. 2017;36(19):2724\u201336.","journal-title":"Oncogene"},{"issue":"7","key":"1580_CR24","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.21873\/anticanres.17098","volume":"44","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Niu X, Wang Y, Bao S, Jiang P, Dong X. SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK\/ERK\/C-Myc Axis. Anticancer Res. 2024;44(7):2861\u201370.","journal-title":"Anticancer Res"},{"issue":"6","key":"1580_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000445323","volume":"90","author":"Y Nakahara","year":"2016","unstructured":"Nakahara Y, Yamasaki M, Sawada G, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mimori K, et al. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma. Oncology. 2016;90(6):347\u201355.","journal-title":"Oncology"},{"issue":"1","key":"1580_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13008-023-00091-w","volume":"18","author":"J Yin","year":"2023","unstructured":"Yin J, Cai G, Wang H, Chen W, Liu S, Huang G. SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy. Cell Div. 2023;18(1):9.","journal-title":"Cell Div"},{"issue":"4","key":"1580_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.02.024","volume":"23","author":"SM Jeong","year":"2013","unstructured":"Jeong SM, Xiao C, Finley LW, Lahusen T, Souza AL, Pierce K, Li YH, Wang X, Laurent G, German NJ, et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell. 2013;23(4):450\u201363.","journal-title":"Cancer Cell"},{"issue":"12","key":"1580_CR28","first-page":"11849","volume":"10","author":"G Huang","year":"2017","unstructured":"Huang G, Lin Y, Zhu G. SIRT4 is upregulated in breast cancer and promotes the proliferation, migration and invasion of breast cancer cells. Int J Clin Exp Pathol. 2017;10(12):11849\u201356.","journal-title":"Int J Clin Exp Pathol"},{"key":"1580_CR29","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.2147\/OTT.S157724","volume":"11","author":"G Huang","year":"2018","unstructured":"Huang G, Zhu G. Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer. Onco Targets Ther. 2018;11:3395\u2013400.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1580_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbrc.2016.01.078","volume":"470","author":"SM Jeong","year":"2016","unstructured":"Jeong SM, Hwang S, Seong RH. SIRT4 regulates cancer cell survival and growth after stress. Biochem Biophys Res Commun. 2016;470(2):251\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1580_CR31","doi-asserted-by":"publisher","first-page":"e0146948","DOI":"10.1371\/journal.pone.0146948","volume":"11","author":"I Mahjabeen","year":"2016","unstructured":"Mahjabeen I, Kayani MA. Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study. PLoS ONE. 2016;11(1):e0146948.","journal-title":"PLoS ONE"},{"issue":"3","key":"1580_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1055\/s-0044-1791681","volume":"19","author":"E Phattarataratip","year":"2025","unstructured":"Phattarataratip E, Lam-Ubol A. Histone H3K9 Methylation Is Differentially Modified in Odontogenic Cyst and Tumors. Eur J Dent. 2025;19(3):688\u201396.","journal-title":"Eur J Dent"},{"issue":"1","key":"1580_CR33","doi-asserted-by":"publisher","first-page":"15063","DOI":"10.1038\/s41598-022-19174-9","volume":"12","author":"A Lam-Ubol","year":"2022","unstructured":"Lam-Ubol A, Phattarataratip E. Distinct histone H3 modification profiles correlate with aggressive characteristics of salivary gland neoplasms. Sci Rep. 2022;12(1):15063.","journal-title":"Sci Rep"},{"issue":"11","key":"1580_CR34","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00405-020-06036-1","volume":"277","author":"F Yan","year":"2020","unstructured":"Yan F, Reddy PD, Nguyen SA, Chi AC, Neville BW, Day TA. Grading systems of oral cavity pre-malignancy: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2020;277(11):2967\u201376.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"1580_CR35","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cell.2013.04.023","volume":"153","author":"A Csibi","year":"2013","unstructured":"Csibi A, Fendt SM, Li C, Poulogiannis G, Choo AY, Chapski DJ, Jeong SM, Dempsey JM, Parkhitko A, Morrison T, et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell. 2013;153(4):840\u201354.","journal-title":"Cell"},{"issue":"4","key":"1580_CR36","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/hep.30421","volume":"69","author":"YS Wang","year":"2019","unstructured":"Wang YS, Du L, Liang X, Meng P, Bi L, Wang YL, Wang C, Tang B. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha\/Mammalian Target of Rapamycin Axis in Mice. Hepatology. 2019;69(4):1614\u201331.","journal-title":"Hepatology"},{"issue":"10","key":"1580_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/jop.12440","volume":"45","author":"F Martins","year":"2016","unstructured":"Martins F, de Sousa SC, Dos Santos E, Woo SB, Gallottini M. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis. J Oral Pathol Med. 2016;45(10):746\u201352.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"1580_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10266-019-00428-4","volume":"108","author":"K Tashiro","year":"2020","unstructured":"Tashiro K, Oikawa M, Miki Y, Takahashi T, Kumamoto H. Immunohistochemical assessment of growth factor signaling molecules: MAPK, Akt, and STAT3 pathways in oral epithelial precursor lesions and squamous cell carcinoma. Odontology. 2020;108(1):91\u2013101.","journal-title":"Odontology"},{"issue":"2","key":"1580_CR39","first-page":"1675","volume":"16","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Wang G, Li X, Wang T, Weng M, Zhang Y. Knockout of SIRT4 decreases chemosensitivity to 5-FU in colorectal cancer cells. Oncol Lett. 2018;16(2):1675\u201381.","journal-title":"Oncol Lett"},{"issue":"17","key":"1580_CR40","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.7150\/thno.100667","volume":"14","author":"H Shen","year":"2024","unstructured":"Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z, Qin Z. Targeting sirtuins for cancer therapy: epigenetics modifications and beyond. Theranostics. 2024;14(17):6726\u201367.","journal-title":"Theranostics"}],"container-title":["Odontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10266-026-01580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10266-026-01580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:23:17Z","timestamp":1791966197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10266-026-01580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":40,"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1007\/s10266-026-01580-4","relation":{},"ISSN":["1618-1247","1618-1255"],"issn-type":[{"value":"1618-1247","type":"print"},{"value":"1618-1255","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"8 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the Human Research Ethics Committee of Faculty of Dentistry, Chulalongkorn University (study code HREC-DCU 2024-052; Approval number 074\/2024).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the Institutional Review Board.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}